Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruud H Brakenhoff

Showing results (91-100 of 192) with videos related to

Pageof 20
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 19, 2025
Prognostic gene expression signatures for HPV-negative head and neck squamous cell carcinomaStefano Cavalieri, Ruud H Brakenhoff, C René Leemans, et al.
Plos One|August 6, 2025
An unexpected role of CLASP1 in radiation response and S-phase regulation of head and neck cancer cellsReinout H de Roest, Marijke Buijze, Myrthe Veth, et al.
Cancers|January 11, 2025
Richness for Tumor-Infiltrating B-Cells in the Oral Cancer Tumor Microenvironment Is a Prognostic Factor in Early-Stage Disease and Improves Outcome in Advanced-Stage DiseaseIrene H Nauta, Dennis N L M Nijenhuis, Sonja H Ganzevles, et al.
Oral Oncology|November 2, 2015
HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?Robert P Takes, Małgorzata Wierzbicka, Gypsyamber D'Souza, et al.
Journal of Proteomics|February 3, 2019
Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response predictionFranziska Böttger, Tieneke B Schaaij-Visser, Inge de Reus, et al.
International Journal of Cancer|February 26, 2021
The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinomaIrene H Nauta, Daniëlle A M Heideman, Arjen Brink, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2014
A comprehensive assessment protocol including patient reported outcomes, physical tests, and biological sampling in newly diagnosed patients with head and neck cancer: is it feasible?Annette J van Nieuwenhuizen, Laurien M Buffart, Jan H Smit, et al.
Journal of Proteomics|January 26, 2011
Protein signatures associated with tumor cell dissemination in head and neck cancerOnno B Bleijerveld, Ruud H Brakenhoff, Tieneke B M Schaaij-Visser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective studyViola M M van Houten, C René Leemans, J Alain Kummer, et al.
Oral Oncology|July 26, 2021
The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysisIrene H Nauta, Thomas Klausch, Peter M van de Ven, et al.
Pageof 20

Showing results (91-100 of 192) with videos related to

Sort By:
Pageof 20
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 19, 2025
Prognostic gene expression signatures for HPV-negative head and neck squamous cell carcinomaStefano Cavalieri, Ruud H Brakenhoff, C René Leemans, et al.
Plos One|August 6, 2025
An unexpected role of CLASP1 in radiation response and S-phase regulation of head and neck cancer cellsReinout H de Roest, Marijke Buijze, Myrthe Veth, et al.
Cancers|January 11, 2025
Richness for Tumor-Infiltrating B-Cells in the Oral Cancer Tumor Microenvironment Is a Prognostic Factor in Early-Stage Disease and Improves Outcome in Advanced-Stage DiseaseIrene H Nauta, Dennis N L M Nijenhuis, Sonja H Ganzevles, et al.
Oral Oncology|November 2, 2015
HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?Robert P Takes, Małgorzata Wierzbicka, Gypsyamber D'Souza, et al.
Journal of Proteomics|February 3, 2019
Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response predictionFranziska Böttger, Tieneke B Schaaij-Visser, Inge de Reus, et al.
International Journal of Cancer|February 26, 2021
The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinomaIrene H Nauta, Daniëlle A M Heideman, Arjen Brink, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2014
A comprehensive assessment protocol including patient reported outcomes, physical tests, and biological sampling in newly diagnosed patients with head and neck cancer: is it feasible?Annette J van Nieuwenhuizen, Laurien M Buffart, Jan H Smit, et al.
Journal of Proteomics|January 26, 2011
Protein signatures associated with tumor cell dissemination in head and neck cancerOnno B Bleijerveld, Ruud H Brakenhoff, Tieneke B M Schaaij-Visser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective studyViola M M van Houten, C René Leemans, J Alain Kummer, et al.
Oral Oncology|July 26, 2021
The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysisIrene H Nauta, Thomas Klausch, Peter M van de Ven, et al.
Pageof 20